NCT03939793

Brief Summary

This randomized controlled trial tests how digital health monitoring with financial incentives (DFI) and community health worker (CHW) support may affect how a person manages their diabetes. Participants will be randomized to one of three arms: 1) DFI intervention, 2) hybrid DFI/CHW intervention, or 3) usual care. Investigators hypothesize that compared to usual care and DFI alone, the hybrid intervention will lead to more glucose self-monitoring and greater improvements in glycosylated hemoglobin.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for not_applicable diabetes-mellitus

Timeline
Completed

Started May 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 3, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 7, 2019

Completed
8 days until next milestone

Study Start

First participant enrolled

May 15, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 28, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 28, 2020

Completed
4.1 years until next milestone

Results Posted

Study results publicly available

September 5, 2024

Completed
Last Updated

September 5, 2024

Status Verified

August 1, 2024

Enrollment Period

1.2 years

First QC Date

May 3, 2019

Results QC Date

September 21, 2023

Last Update Submit

August 30, 2024

Conditions

Keywords

Community Health WorkerFinancial Incentives

Outcome Measures

Primary Outcomes (1)

  • Glucose Self-monitoring Adherence

    constructed by summing the number of days in the study period that the glucometer was used divided by the total number of days in study period

    3 months

Other Outcomes (1)

  • Change in Glycosylated Hemoglobin

    6 months

Study Arms (3)

Usual Clinical Support

PLACEBO COMPARATOR

Participants will continue with their usual diabetes care provided by their clinic. Participants will receive a free wireless glucometer on the day of enrollment if they do not already have one.

Other: Usual Care

DFI Alone

ACTIVE COMPARATOR

Participants will receive a free wireless glucometer on the day of enrollment if they don't already have one. To encourage habit formation, for the first 6 weeks of the trial, participants will be eligible for a daily lottery incentive for every day that they use their glucometer. Investigators will use an approach similar to what we have used in prior DFI trials: the lottery will provide infrequent large payoffs (a 1 in 100 chance of a US$50 reward) and more frequent small payoffs (an 18 in 100 chance of a US $5 reward). Participants who draw the winning lottery number, but did not check their glucose the day prior will receive an automated text or e-mail message informing them what earnings they would have won had they used their glucometer. After 6 weeks, investigators will terminate the lottery but continue to monitor patients' adherence to glucose self-monitoring.

Behavioral: Digital health monitoring with financial incentives

Hybrid DFI CHW

EXPERIMENTAL

Participants in the hybrid intervention will receive a wireless glucometer if they don't already have one and financial incentives just as in the DFI intervention. However, any individuals who have low adherence (no self-monitoring) or elevated glucose readings (\>300 mg/dL) for \>30% of days over any 2 week period in the first 12 weeks of the study will be assigned to receive ongoing community health worker (CHW) support for the duration of the 24-week study period.

Behavioral: IMPaCT Community Health WorkerBehavioral: Digital health monitoring with financial incentives

Interventions

Once a CHW receives notification of a struggling patient, the CHW will visit the patient at their home within 1-2 days to initiate the IMPaCT intervention. 1. Elements of the standard IMPaCT intervention: During the first home visit, the CHW will use an in-depth semi-structured interview guide to get to know patients holistically and assess for unmet socioeconomic needs. This allows patients to express goals in line with their own needs and preferences. These individualized goals will become the basis for tailored action plans. The CHW will then provide hands-on, tailored support for the remainder of the 24-week study period to help patients achieve their goals. 2. Additional elements to help patients cope with failure: In this study, we will test a refined version of IMPaCT that incorporates two behavioral techniques for coping with failure: positive affect induction and attribution retraining.

Hybrid DFI CHW

Participants are encouraged to use their glucometer to check their blood glucose via bidirectional texting and lottery-based financial incentives, which both serve to reinforce self-monitoring behavior.

DFI AloneHybrid DFI CHW

Usual Care

Usual Clinical Support

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Penn Medicine patients diagnosed with diabetes mellitus.
  • Glycosylated hemoglobin \>=9% within the past 6 months.
  • Requires insulin.
  • Uninsured/publicly insured.
  • Residents of high-poverty ZIP codes in West/Southwest Philadelphia.
  • Have access to a cellphone with unlimited text message capabilities.

You may not qualify if:

  • Already have a continuous glucose monitor.
  • Previously enrolled in the study.
  • Currently have an outpatient CHW.
  • Unwilling/unable to provide informed consent.
  • In another study that asks participants to monitor their blood sugar.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Penn Medicine

Philadelphia, Pennsylvania, 19104, United States

Location

Related Publications (1)

  • Whitehouse CR, Knowles M, Long JA, Mitra N, Volpp KG, Xu C, Sabini C, Gerald N, Estrada I, Jones D, Kangovi S. Digital Health and Community Health Worker Support for Diabetes Management: a Randomized Controlled Trial. J Gen Intern Med. 2023 Jan;38(1):131-137. doi: 10.1007/s11606-022-07639-6. Epub 2022 May 17.

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Limitations and Caveats

The COVID pandemic may have led to a higher-than-expected rate of loss to follow-up at 6 months. A COVID-19 modification truncated our primary outcome from 6 to 3 months. Unlike many DHI requiring smartphones, we only required participants to have a basic cell phone; participants needed to text their SMBG to the study platform which may have increased attrition. Because we used low-tech glucometers covered by Medicaid, we extracted data from the physical device, resulting in some missing data.

Results Point of Contact

Title
Director of Evaluation
Organization
Penn Center for Community Health Workers

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 3, 2019

First Posted

May 7, 2019

Study Start

May 15, 2019

Primary Completion

July 28, 2020

Study Completion

July 28, 2020

Last Updated

September 5, 2024

Results First Posted

September 5, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations